71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results
暂无分享,去创建一个
D. Nuyten | R. Ferris | R. Mehra | B. Burtness | L. Nabell | J. Bauman | N. Saba | D. Laux | M. Gibson | P. Neupane | Ezra E. W. Cohen | D. Zandberg | J. Kaczmar | A. Desbien | D. Adkins | R. Julian | C. Bermingham | Y. Kim | A. DuPage | A. Loi